Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 1

1(16.7%)

6Total

N/A(5)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05868161Recruiting

Pounce™ Thrombectomy System Retrospective Registry

Role: lead

NCT03241459Not ApplicableCompleted

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

Role: lead

NCT03734679Not ApplicableCompleted

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (AVess FIH)

Role: lead

NCT05600816Not ApplicableNot Yet Recruiting

SurmodiCs Pounce Venous THrOMbectomy System Post Market Clinical Follow Up Study

Role: lead

NCT04107298Not ApplicableCompleted

Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon

Role: lead

NCT00915837Phase 1Completed

Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema

Role: lead

NCT02648620Not ApplicableCompleted

Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon

Role: lead

All 7 trials loaded